Fosun International Ltd lifted its position in shares of iKang Healthcare Group, Inc. (NASDAQ:KANG) by 40.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,571,138 shares of the medical research company’s stock after purchasing an additional 1,023,199 shares during the quarter. iKang Healthcare Group accounts for 4.8% of Fosun International Ltd’s portfolio, making the stock its 11th largest position. Fosun International Ltd owned approximately 5.14% of iKang Healthcare Group worth $48,139,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in KANG. Athos Capital Ltd bought a new position in shares of iKang Healthcare Group during the second quarter worth $8,622,000. SG Americas Securities LLC lifted its position in iKang Healthcare Group by 14.6% in the 2nd quarter. SG Americas Securities LLC now owns 44,608 shares of the medical research company’s stock valued at $547,000 after acquiring an additional 5,700 shares in the last quarter. FIL Ltd lifted its position in iKang Healthcare Group by 45.4% in the 2nd quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock valued at $4,429,000 after acquiring an additional 112,615 shares in the last quarter. GLG Partners LP lifted its position in iKang Healthcare Group by 15.5% in the 2nd quarter. GLG Partners LP now owns 1,754,570 shares of the medical research company’s stock valued at $21,529,000 after acquiring an additional 235,056 shares in the last quarter. Finally, Pictet Asset Management Ltd. bought a new stake in iKang Healthcare Group in the 3rd quarter valued at $330,000. 33.11% of the stock is currently owned by institutional investors.
Shares of iKang Healthcare Group, Inc. (KANG) opened at $14.44 on Wednesday. iKang Healthcare Group, Inc. has a 52-week low of $11.70 and a 52-week high of $18.41. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.78 and a quick ratio of 0.76.
iKang Healthcare Group (NASDAQ:KANG) last posted its quarterly earnings data on Thursday, September 14th. The medical research company reported $0.06 EPS for the quarter. iKang Healthcare Group had a negative net margin of 2.16% and a negative return on equity of 2.68%. The business had revenue of $115.60 million for the quarter.
Separately, BidaskClub raised shares of iKang Healthcare Group from a “sell” rating to a “hold” rating in a research report on Tuesday, August 15th.
COPYRIGHT VIOLATION NOTICE: “iKang Healthcare Group, Inc. (KANG) Stake Boosted by Fosun International Ltd” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://ledgergazette.com/2017/12/06/ikang-healthcare-group-inc-kang-stake-boosted-by-fosun-international-ltd.html.
About iKang Healthcare Group
iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.
Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.